Case studies in therapeutics: warfarin resistance and inefficacy in a man with recurrent thromboembolism, and anticoagulant-associated priapism.

Br J Clin Pharmacol

Department of Pharmacology, Therapeutics and Toxicology, University of Wales College of Medicine, East Glamorgan Hospital, Cardiff.

Published: October 1998

AI Article Synopsis

Article Abstract

A 52 year-old male unemployed labourer was referred because of recurrent thromboembolism. An episode of thrombophlebitis migrans 3 months earlier had been followed by a pulmonary embolus a week later, and then a deep vein thrombosis despite apparently adequate anticoagulant therapy with warfarin 10 mg daily (INRs between 2 and 4). For 9 years he had suffered from hypertension for which he took lisinopril 2.5 mg daily, had smoked 20 cigarettes daily since his teens and drank 12–15 pints of beer each week. On presentation, his right leg remained hot, swollen and tender to the thigh but there were no other abnormal findings. Investigations revealed a normochromic, normocytic anaemia (Hb 11.6 g dl ) and his erythrocyte sedimentation rate, which had been 11 mm h, had risen to 35 mm h. Renal and liver function tests, autoantibody screen, and prostate-specific antigen were normal. Antithrombin III, protein C and S concentrations were all within normal limits and ultrasound of the abdomen and pelvis, barium meal and enema, and CT of the thorax, abdomen and pelvis, bronchoscopy and brushings also failed to reveal any abnormality. .

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874165PMC
http://dx.doi.org/10.1046/j.1365-2125.1998.t01-1-00796.xDOI Listing

Publication Analysis

Top Keywords

recurrent thromboembolism
8
abdomen pelvis
8
case studies
4
studies therapeutics
4
therapeutics warfarin
4
warfarin resistance
4
resistance inefficacy
4
inefficacy man
4
man recurrent
4
thromboembolism anticoagulant-associated
4

Similar Publications

Background:  The benefits and risks of extending anticoagulant treatment beyond the first 3 to 6 months in patients with venous thromboembolism (VTE) in clinical practice are not well understood.

Methods:  ETNA-VTE Europe is a prospective, noninterventional, post-authorization study in unselected patients with VTE treated with edoxaban in eight European countries for up to 18 months. Recurrent VTE, major bleeding, and all-cause death were the primary study outcomes.

View Article and Find Full Text PDF

Background: Patients with atrial fibrillation (AF) who suffered a previous stroke are at increased risk of recurrent thromboembolic events and other major outcomes. The impact of the number of stroke episodes on the natural history of patients with AF is still unclear.

Methods And Results: Using data from the international, multicenter, and prospective GLORIA-AF (Global Registry on Long-Term Oral Antithrombotic Treatment in Patients With Atrial Fibrillation) Registry Phase III, we categorized patients with a recent diagnosis of non-valvular AF according to the number of previous strokes (either 0, 1, or ≥2 episodes).

View Article and Find Full Text PDF

Background: Recent data showed an association between malnutrition and increased all-cause mortality and thromboembolic risk in patients with atrial fibrillation (AF). However, the impact of malnutrition on the clinical outcomes for patients undergoing catheter ablation for AF is still debated. Our study aimed to examine this relationship using all existing available data.

View Article and Find Full Text PDF

Background: Cerebral venous sinus thrombosis (CVST) is a rare type of thrombosis that affects the cerebral venous system. The data on neurological outcomes are limited.

Objectives: This study aimed to investigate the neurological outcomes of CVST, contributing factors, clinical presentation, treatment and mortality.

View Article and Find Full Text PDF

Background: Although there have been reports that green tea intake has thromboprophylactic effect, it was still unknown whether it had adjuvant effect on the basis of conventional anticoagulation for patients diagnosed with venous thromboembolism (VTE).

Methods: VTE patients were retrospectively classified into green tea group and no green tea group in a 1:1 ratio using propensity score matching, based on whether they drank green tea during the 3 months' period after VTE diagnosis. Primary outcomes were VTE recurrence at 3 months after VTE diagnosis and VTE-related death during 3 months after VTE diagnosis.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!